Terry Smith sells Reckitt Benckiser. Should I sell too?

Terry Smith, a high-profile fund manager, has sold his stake in Reckitt Benckiser. Nadia Yaqub digs deeper.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The star fund manager, Terry Smith has sold his entire holding of Reckitt Benckiser (LSE: RB). This sale, which occurred last month, ends Smith’s long-term backing of the company.

Smith set up his investment house, Fundsmith, in 2010 and has held a stake in Reckitts for over a decade. The company was part of the original Fundsmith Equity portfolio, a £23bn concentrated fund of 30 global stocks.

The high profile manager has not mentioned the reasons behind his sale of RB. Smith’s exit is timely as the shares have been falling. Investors are concerned that the strong demand for hygiene and health products, which lifted sales during the pandemic is unlikely to continue.

Should I sell too? Let’s take a closer look.

Portfolio of brands

Reckitts has a strong brand portfolio including Dettol and Lysol, which have performed well during the pandemic. No one could have predicted the chaos of Covid-19 but it has worked in the company’s favour.

Recent results saw Reckitts upgrade its sales forecast. The consumer group now expects revenue to grow by “low double digits” rather than the previous “high single digit“. Board members clearly expect the high demand to continue, but I am unsure.

Long-term trend

The excitement of a Covid-19 vaccine has pushed down the share price. The company has been a clear winner of the pandemic, and management thinks that the current crisis will translate into a long-term behaviour shift.

While I appreciate that Covid-19 has been a catalyst for Reckitts, I am not convinced that this level of demand for its health and hygiene products can be sustained in the long term.

Strategic review

In September 2019, Laxman Narasimhan took over from Rakesh Kapoor as CEO of Reckitt Benckiser. Narasimhan immediately conducted a strategic review of the business and announced that he believed the company can grow its revenue by a “mid single digit” in the medium term.

As part of this strategic review, Reckitts expects to deliver a three-phase rejuvenation programme, which started earlier this year. The company will invest £2bn over three years to improve growth.

The arrival of a new CEO means a fresh strategy, especially when Reckitts has delivered poor results in recent years. While it is still early days to assess the performance Narasimhan’s plan, I believe the company is being ambitious with its targets.

Ongoing problems

Reckitt Benckiser has had its fair share of problems. Recent years has seen it deliver disappointing results. In February the company took a £5bn hit on its 2017 acquisition of baby formula maker, Mead Johnson.

In addition, Reckitts has battled a scandal over deadly humidifier disinfectant in South Korea, a cyber attack, and a $1.4bn settlement with the US regulator over its former subsidiary’s marketing of an addiction drug.

My verdict

The chairman, Christopher Sinclair, may be buying Reckitt Benckiser shares on the dip. But if I held the shares, I’d likely follow the example of Train, and sell. The company has an attractive dividend yield of approximately 2.5% but I want to see some evidence of the rejuvenation programme working in a post Covid-19 world before buying.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Nadia Yaqub has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

3 ideas to help investors aim for a million-pound Stocks & Shares ISA

The UK has a growing number of Stocks and Shares ISA millionaires, and this plan may be one of the…

Read more »

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »